logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Bladder cancer: adding ramucirumab does not worsen QoL vs docetaxel alone

QoL data from phase 3 RANGE study is reassuring for patients.